Dan McLaughlin points out a… let’s say… significant caveat about that study showing trillions in “cuts” to states in the latest Senate GOP health care proposal:
The study finds a $215 billion-over-seven-years reduction in spending from 2020-2026, but then jumps up to $489 billion when one more year is added, and ends up at $4.15 trillion by 2036. Why? Because Graham-Cassidy provides funding through 2026, then requires an affirmative reauthorization of the block grants after that. Avalere treats that “funding cliff” as if Congress has barred future funding. (“As the bill does not appropriate block grant funding to states after 2026, Avalere does not assume any state block grant funding available from 2027 onwards.”) Even over the full 17-year time horizon, as CAP Health Care analyst Topher Spiro confirmed to me on Twitter, the study assumes $1 trillion in cuts from the changed funding formula, meaning that 75% of the projected “cuts” are attributable entirely to the program requiring further authorization by Congress by 2026.
So, basically, researchers with integrity would have limited their time line to the period actually covered by the legislation. When 2026, either the program would be working well and therefore be easily renewed or it wouldn’t be working well and Congress would have to come up with something else. But the objective of this study — which the long window of itself strongly suggests — was clearly to stoke fear and gin up outrage.
Of course, as I emphasized last week, what really ought to be scaring Americans is the cost of ObamaCare if nothing is done. Somehow, that angle doesn’t make it into the reporting, though.